Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$46.98−0.91 (-1.90%)
Close on Nov 12, 2026Market cap $7.88BP/E 123.6Yield –
Alkermes operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Alkermes's operating cash flow for the twelve months ending Jun 30, 2026 was $251.18M, down 51.8% year over year. For fiscal 2025 it was $520.75M, up 18.6% from the year before. The highest annual figure on record is $520.75M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $520.75M | +18.6% |
| FY2024 | Dec 31, 2024 | $439.12M | +9.4% |
| FY2023 | Dec 31, 2023 | $401.35M | +1807.2% |
| FY2022 | Dec 31, 2022 | $21.04M | -79.3% |
| FY2021 | Dec 31, 2021 | $101.72M | +22.8% |
| FY2020 | Dec 31, 2020 | $82.84M | +14.9% |
| FY2019 | Dec 31, 2019 | $72.08M | -27.4% |
| FY2018 | Dec 31, 2018 | $99.28M | +417.4% |
| FY2017 | Dec 31, 2017 | $19.19M | – |
| FY2016 | Dec 31, 2016 | -$63.80M | – |
| FY2015 | Dec 31, 2015 | -$40.36M | -131.9% |
| FY2013 | Mar 31, 2013 | $126.55M | – |
| FY2012 | Mar 31, 2012 | -$2.48M | – |
| FY2011 | Mar 31, 2011 | -$5.91M | – |
| FY2010 | Mar 31, 2010 | -$12.25M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $145.18M | -3.3% |
| Q1 FY2026 | Mar 31, 2026 | -$165.74M | -267.7% |
| Q4 FY2025 | Dec 31, 2025 | $170.07M | -10.7% |
| Q3 FY2025 | Sep 30, 2025 | $101.67M | +24.6% |
| Q2 FY2025 | Jun 30, 2025 | $150.20M | +2.9% |
| Q1 FY2025 | Mar 31, 2025 | $98.81M | +368.1% |
| Q4 FY2024 | Dec 31, 2024 | $190.40M | +77.5% |
| Q3 FY2024 | Sep 30, 2024 | $81.59M | -18.2% |
| Q2 FY2024 | Jun 30, 2024 | $146.03M | -32.3% |
| Q1 FY2024 | Mar 31, 2024 | $21.11M | – |
| Q4 FY2023 | Dec 31, 2023 | $107.24M | +10142.3% |
| Q3 FY2023 | Sep 30, 2023 | $99.71M | +15853.3% |
| Q2 FY2023 | Jun 30, 2023 | $215.71M | – |
| Q1 FY2023 | Mar 31, 2023 | -$21.30M | -198.3% |
| Q4 FY2022 | Dec 31, 2022 | $1.05M | -96.6% |
| Q3 FY2022 | Sep 30, 2022 | $625.00K | -99.2% |
| Q2 FY2022 | Jun 30, 2022 | -$2.31M | -107.0% |
| Q1 FY2022 | Mar 31, 2022 | $21.68M | – |
| Q4 FY2021 | Dec 31, 2021 | $31.02M | -53.9% |
| Q3 FY2021 | Sep 30, 2021 | $82.78M | +37.5% |
| Q2 FY2021 | Jun 30, 2021 | $33.06M | – |
| Q1 FY2021 | Mar 31, 2021 | -$45.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $67.34M | +60.1% |
| Q3 FY2020 | Sep 30, 2020 | $60.20M | +94.4% |
| Q2 FY2020 | Jun 30, 2020 | -$4.43M | – |
| Q1 FY2020 | Mar 31, 2020 | -$40.27M | -281.3% |
| Q4 FY2019 | Dec 31, 2019 | $42.07M | -30.5% |
| Q3 FY2019 | Sep 30, 2019 | $30.97M | -7.5% |
| Q2 FY2019 | Jun 30, 2019 | -$23.18M | -172.1% |
| Q1 FY2019 | Mar 31, 2019 | $22.21M | – |
| Q4 FY2018 | Dec 31, 2018 | $60.51M | +68.5% |
| Q3 FY2018 | Sep 30, 2018 | $33.48M | +71.9% |
| Q2 FY2018 | Jun 30, 2018 | $32.13M | – |
| Q1 FY2018 | Mar 31, 2018 | -$26.84M | – |
| Q4 FY2017 | Dec 31, 2017 | $35.91M | +375.1% |
| Q3 FY2017 | Sep 30, 2017 | $19.48M | +32.2% |
| Q2 FY2017 | Jun 30, 2017 | -$22.45M | – |
| Q1 FY2017 | Mar 31, 2017 | -$13.75M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $14.73M | – |
See a number that looks wrong?